SEC Form 4 · accession 0001140361-18-029427
Fibrocell Science, Inc. · FCSC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Julian P. Kirk
Director
Period of report
Jun 19, 2018
Accepted (ET)
Jun 21, 2018 · 11:08 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000357097
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common StockF1 | $2.36 | Jun 19, 2018 | A | 6,000 | A | — | Jun 19, 2028 | Common Stock | 6,000 | 6,000 | D |
Explanation of responses
- F1This option is exercisable with respect to 3,000 shares on the earlier of (i) June 19, 2019 or (ii) the date of the issuer's 2019 Annual Meeting of Stockholders, subject to the grantee's continued service on the Board of Directors of the issuer through this date. This option is exercisable with respect to the remaining 3,000 shares on the earlier of (i) June 19, 2020 or (ii) the date of the issuer's 2020 Annual Meeting of Stockholders, subject to the grantee's continued service on the Board of Directors of the issuer through this date.